Artiva Biotherapeutics, Inc. Income Statement

Income Statement Dec2023 Dec2024
Revenue & cost
Revenue 33.49M0.25M
Gross Profit 33.49M0.25M
Operating items
Research & Development 50.25M50.33M
Selling, General & Administrative 13.91M17.20M
Operating Expenses 64.16M67.53M
Operating Income -30.67M-67.28M
EBIT -30.67M-67.28M
Non-operating items
Interest & Investment Income 2.54M5.35M
Other Non Operating Income -0.71M-3.60M
Non Operating Income 2.02M1.91M
Net income details
EBT -28.65M-65.37M
Tax Provisions 0.07M
Profit After Tax -28.72M-65.37M
Income from Continuing Operations -28.72M-65.37M
Consolidated Net Income -28.72M-65.37M
Income towards Parent Company -28.72M-65.37M
Net Income towards Common Stockholders -28.72M-65.37M
Additional items
EPS (Basic) -0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 8.88M24.29M
Shares Outstanding (Diluted Average) 0.80M11.26M
EBITDA -28.41M-65.81M
Shares Outstanding 0.81M24.29M